AN2 Therapeutics ANTX SEC Filings

NASDAQ ANTX
$5.89 -0.06 (-1.01%)
At close: Sep 4, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document AN2 Therapeutics, Inc. (ANTX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index